首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 欧盟EMA儿科检查计划(PIP)的意见和决定(本栏目收费,不能显示细节,电话13136136841)
治疗领域:
活性成分:
药物剂型:
合规检查:
不限
不合格
合格
给物途径:
决定日期:
-
格式:2020-5-3
欧盟人兽用药
欧盟使用中药
欧盟孤儿药
欧盟儿科检查计划(PIP)
欧盟国家授权药品
欧盟推荐药品
欧盟人兽所有意见
欧盟人兽撤回申请
欧盟成员国产品信息
 欧盟EMA儿科检查计划(PIP)的意见和决定2122条(本栏目收费,不能显示细节,电话13136136841)
活性物质
治疗领域
决定日期
合规检查
状态
药物剂型
给物途径
合规意见日期
Betula pendula, Corylus avellana, Alnus glutinosa
Pneumology-allergology
2015/11/27 1:00:00
no
Treatment of allergic rhinitis, Treatment of rhino-conjuctivitis
Oromucosal solution
Sublingual use
1970/1/1 2:00:00
highly purified single-stranded, 5’-capped mRNA encoding full-length SARS-CoV-2 spike protein (BNT162b2)
Vaccines
2020/11/27 1:00:00
no
Prevention of Coronavirus disease 2019 (COVID-19)
Concentrate for solution for injection
Intramuscular use
1970/1/1 2:00:00
mRNA that encodes for the pre-fusion stabilized spike glycoprotein of SARS-CoV-2 (mRNA-1273)
Vaccines
2020/11/30 1:00:00
no
Prevention of Coronavirus disease 2019 (COVID-19)
Suspension for injection
Intramuscular use
1970/1/1 2:00:00
Purified antigen fractions of inactivated split virion Influenza A/Indonesia/5/05 (H5N1)
Vaccines
2009/4/24 0:00:00
no
Influenza infection caused by an influenza strain contained in the vaccine or related to a strain contained in the vaccine
Emulsion and suspension for emulsion for injection
Intramuscular injection
1970/1/1 2:00:00
Molidustat (sodium)
Haematology-Hemostaseology
2014/10/27 1:00:00
no
Treatment of anaemia due to chronic disorders
Film-coated tablet, Oral liquid
Oral use
1970/1/1 2:00:00
fremanezumab
Neurology
2017/12/19 1:00:00
no
Prevention of cluster headaches
Solution for injection
Intravenous use, Subcutaneous use
1970/1/1 2:00:00
tilmanocept
Diagnostic
2018/4/11 0:00:00
no
Visualisation of lymphatic drainage of solid malignant tumours for diagnostic purposes
Kit for radiopharmaceutical preparation
Intradermal use, Subcutaneous use, Intratumoral use, Peritumoural use, Intralymphatic use, Interstitial use
1970/1/1 2:00:00
meropenem trihydrate
Infectious diseases
2015/10/22 0:00:00
no
Treatment of Gram-negative bacterial infections
Powder for solution for infusion
Intravenous use
1970/1/1 2:00:00
N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl) cyclobutyl)-3-phenylisoxazole-5-
Pneumology-allergology
2019/5/17 0:00:00
no
Treatment of cystic fibrosis
Oral use
Capsule, hard, Age-appropriate oral dosage form
1970/1/1 2:00:00
canagliflozin
Endocrinology, -gynacology-fertility-metabolism
2017/8/9 0:00:00
no
Treatment of type II diabetes mellitus
Tablet
Oral use
1970/1/1 2:00:00
Anti-mucosal addressin cell adhesion molecule antibody (SHP647)
Gastroentology-Hepatology
2018/9/12 0:00:00
no
Treatment of Crohn's disease, Treatment of ulcerative colitis
Solution for injection
Subcutaneous use
1970/1/1 2:00:00
Fevipiprant
Pneumology-allergology
2019/9/10 0:00:00
no
Treatment of asthma
Tablet, Chewable tablet, Age-appropriate oral liquid dosage form
Oral use
1970/1/1 2:00:00
captopril
Cardiovascular diseases
2014/8/8 0:00:00
no
Treatment of heart failure
Age-appropriate oral liquid dosage form
Oral use
1970/1/1 2:00:00
Eladocagene exuparvovec
Neurology
2020/3/18 1:00:00
no
Treatment of aromatic L-amino acid decarboxylase deficiency
Solution for infusion, Concentrate for solution for injection
Intracerebral use, Intracerebroventricular use, Intracisternal use, Intrathecal use
1970/1/1 2:00:00
Evinacumab
Endocrinology, -gynacology-fertility-metabolism
2020/3/18 1:00:00
no
Treatment of elevated cholesterol
Solution for infusion
Intravenous use
1970/1/1 2:00:00
bupivacaine, meloxicam (HTX-011)
Pain
2020/3/18 1:00:00
no
Treatment of acute postoperative pain
Solution for injection
Application to surgical site
1970/1/1 2:00:00
Risdiplam (RO7034067)
Neurology
2020/3/18 1:00:00
no
Treatment of spinal muscular atrophy
Powder for oral solution
Oral use
1970/1/1 2:00:00
Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A (H1N1), Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A (H3N2), Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain B (Yamagata lineage), Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain B (Victoria lineage) [QIVc]
Vaccines
2020/3/18 1:00:00
no
Prevention of influenza
Suspension for injection
Intramuscular use
1970/1/1 2:00:00
Emapalumab
Immunology-Rheumatology-Transplantation
2020/3/20 1:00:00
no
Treatment of haemophagocytic lymphohistiocytosis
Concentrate for solution for infusion
Intravenous use
1970/1/1 2:00:00
Entrectinib
Oncology
2019/1/4 1:00:00
no
Treatment of all conditions induded in the category of malignant neoplasms ( except haematopoietic and lymphoid tissue neoplasms)
Capsule, hard, Coated granules
Oral use, Gastric use
1970/1/1 2:00:00
首页
(current)
3
(current)
4
(current)
5
(current)
6
(current)
7
(current)
8
(current)
9
(current)
10
(current)
11
(current)
12
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
医药研究数据
|
医药资料
|
SDA药品评审中心
|
中医网
|
中药处方系统
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: